secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2022-10-04T23:59:59+00:00
Accession:  0001493152-22-027568
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma adjourns special shareholders meeting due to lack of quorum; reconvened Oct 10
--------------------------------------------------------------------------------

- Special meeting on Sept 28 lacked quorum; adjourned to Oct 10, 2022 at 11 a.m. PST.
- Record date remains Aug 8, 2022; prior votes count unless changed.
- Proposal unchanged: ratify discretionary broker voting on authorized share reduction from 750M to 250M.
- Company urges all shareholders to vote by Oct 9 to ensure quorum at reconvened meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315222027568/0001493152-22-027568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315222027568/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-027568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer